Nexien BioPharma, Inc (OTC: NXEN) CEO Interview with Alex Wasyl discussing the company’s cannabinoid-based drug development pipeline. Drug development targets include, epliepsy, myotonia and other markets.
Constellation Brands Inc. (NYSE: STZ) CEO Robert Sands, discusses continued market penetration of the company’s Mexican beer brands, Pacifico, Victoria in US, and global cannabis strategy, including potential of CBD beverages, and Canopy Growth (NYSE: […]
New preclinical data using a humanized mouse model confirms and expands on the potential use of leronlimab in treating this inflammatory syndrome, a common precursor to NASH VANCOUVER, Washington, Nov 21, 2019 — CytoDyn Inc. […]
DENVER, March 21, 2019 -Medicine Man Technologies, Inc. (otcqx:MDCL) (“Medicine Man Technologies” or “Company”), a rapidly growing, vertically integrated cannabis operator, today announced it will be presenting at the Sidoti & Company, LLC, Spring 2019 […]
Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.
